Name: Nitrogen Heterocycles in Cancer Therapy
Price: 175 USD
Availability: InStock
ISBN: 9780443331060

Nitrogen Heterocycles in Cancer Therapy, 1st Edition, provides an academic reference detailing the chemical design, synthetic pathways, and biological mechanisms of nitrogen-containing heterocyclic molecules. Authors Sanjeev Kumar Sahu and Ankur Vaidya present systematic evaluations of heterocyclic structures designed for oncological applications. The volume supports researchers in biosciences, oncology, pharmaceutical sciences, and nanomedicine drug delivery by summarizing core chemical features and biological actions.

The text organizes chemical frameworks by ring size and heteroatom composition, starting with three- and four-membered nitrogen-containing heterocyclic compounds. It progresses to five-membered systems including pyrrole and pyrazole derivatives, followed by six-membered rings such as pyridine, pyrimidine, piperidine, and triazine. Specialized chapters also evaluate azoles, highlighting triazole and imidazole scaffolds used in anticancer drug design.

Additional coverage highlights purine derivatives used in modern cancer therapy. Designed to serve clinicians, academic researchers, and graduate students, this reference provides structured insights into chemical synthesis and targeted drug discovery.

Chapter 1: Introduction to heterocyclic nucleus-based nitrogen-containing anticancer compounds
Chapter 2: Three and Four-Member Nitrogen-Containing Heterocyclic Compounds as Anticancer Agents
Chapter 3: Five membered nitrogen-containing heterocyclic compounds (pyrrole and pyrazole derivatives) as anticancer compounds
Chapter 4: Six membered nitrogen-containing heterocyclic compounds (Pyridine, pyrimidine, piperidine and triazine) as anticancer compounds
Chapter 5: Azoles (triazole and imidazole) scaffolds in anticancer drug design
Chapter 6: Purine derivatives in cancer therapy
Chapter 7: Indole scaffolds in anticancer drug discovery
Chapter 8: Benzimidazole, benzothiazole and benzoxazole derivatives as potential anticancer agents
Chapter 9: Quinoline, isoquinoline and quinoxaline derivatives as promising anticancer agents
Chapter 10: Miscellaneous fused heterocyclic compounds (β-lactam derivatives, Carbazoles, Isatin derivatives, Pyrrolo-Benzodiazepines, Pyrido[2,3-d] Pyrimidine Derivatives) as anticancer compounds